SCHEMBL4629778

SCHEMBL4629778

CCOC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1

nearest known ligand 0.77

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.77
ALDH1A1 P00352 5/20 0.77
HSD17B10 Q99714 3/20 0.76
LMNA P02545 3/20 0.76
HPGD P15428 2/20 0.76
MAPT P10636 1/20 0.76
CYP1A2 P05177 1/20 0.68
TOP2A P11388 1/20 0.68
CYP2C9 P11712 1/20 0.68
TOP2B Q02880 1/20 0.68
PIK3CG P48736 7/20 0.65
PIK3CD O00329 5/20 0.65
PIK3R1 P27986 5/20 0.65
PIK3CA P42336 5/20 0.65
HTT P42858 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HRH3 Q9Y5N1 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15506946 0.93 KDM4E (0.68) KDM4EALDH1A1HSD17B10LMNAHPGD
SCHEMBL11010069 0.92 KDM4E (0.71) KDM4EALDH1A1HSD17B10LMNAHPGD
SCHEMBL10919718 0.90 KDM4E (0.80) KDM4EALDH1A1HSD17B10LMNAHPGD
SCHEMBL10809619 0.90 KDM4E (0.70) KDM4EALDH1A1HSD17B10LMNAHPGD
SCHEMBL13488506 0.89 KDM4E (0.70) KDM4EALDH1A1HSD17B10LMNAHPGD
SCHEMBL11003102 0.89 KDM4E (0.71) KDM4EALDH1A1HSD17B10LMNAHPGD
SCHEMBL10922729 0.89 ALDH1A1 (0.61) KDM4EALDH1A1HSD17B10LMNAHPGD
SCHEMBL5006578 0.89 KDM4E (0.77) KDM4EALDH1A1HSD17B10LMNAHPGD
SCHEMBL30306078 0.89 KDM4E (0.77) KDM4EALDH1A1HSD17B10LMNAHPGD
SCHEMBL10924388 0.89 KDM4E (0.80) KDM4EALDH1A1HSD17B10LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1711468-B1 PROCESS FOR PREPARING PURIFIED CIPROFLOXACIN KRKA TOVARNA ZDRAVIL D D NOVO (SI) 2008-05-14 EP disclosed
EP-1711468-A1 PROCESS FOR PREPARING PURIFIED CIPROFLOXACIN KRKA, tovarna zdravil, d.d., Novo mesto (SI) 2006-10-18 EP disclosed
WO-2005075430-A1 PROCESS FOR PREPARING PURIFIED CIPROFLOXACIN KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) 2005-08-18 WO disclosed
CN-1091103-C Compounds of carbostyrils and their preparation and use SHANGHAI MEDICINE INST CHINESE (CN) 2002-09-18 CN disclosed
CN-1234397-A Compounds of carbostyrils and their preparation and use SHANGHAI MEDICINE INST CHINESE (CN) 1999-11-10 CN disclosed
EP-0117473-B1 QUINOLONE CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND ANTIBACTERIAL COMPOSITIONS CONTAINING THEM BAYER AG (DE) 1987-01-28 EP disclosed
EP-0121727-B1 BACTERICIDAL AGENT BASED ON QUINOLONECARBOXYLIC ACIDS BAYER AG (DE) 1986-09-24 EP disclosed
US-4559341-A Quinolonecarboxylic acids and antibacterial agents containing these compounds BAYER AKTIENGESELLSCHAFT (DE) 1985-12-17 US disclosed
EP-0121727-A1 Bactericidal agent based on quinolonecarboxylic acids BAYER AG (DE) 1984-10-17 EP disclosed
EP-0117473-A1 Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them BAYER AG (DE) 1984-09-05 EP disclosed